BAE Systems also came under pressure, falling 24p to 1797p despite its upgrade to 2025 guidance. GSK also surrendered initial ...

Red hot Rolls-Royce and the latest strong performance by Shell today fuelled another FTSE 100 index record during a packed ...

Revenue declined sharply to $8.7 million in Q2 fiscal year 2025, missing analyst expectations by 34.1% and falling 55.8% compared to the prior year period. Net loss widened to $50.5 million for Q2 ...

Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today. ... Read More The post Rise and Shine: Everything you need to know before the ASX opens ...

Shares of GSK PLC GSK slid 3.04% to £14.18 Thursday, on what proved to be an all-around rough trading session for the stock ...

GSK's GSK +0.59% Get Free Report short percent of float has fallen 27.17% since its last report. The company recently reported that it has 13.51 million shares sold short, which is 0.67% of all ...

GlaxoSmithKline ( ($GSK) ) has released its Q2 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors.

British consumer healthcare group Haleon lowered its annual revenue growth forecast to about 3.5% on Thursday after ...

Wall Street stocks rose on Wednesday as the US economy grew much faster than expected in the second quarter of 2025. GDP grew ...

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that its president and chief executive officer, Jon Stonehouse, has informed the board of directors of his intention to retire on December ...